BioSpace News Archive

Deals

Pharma, Life Sciences Sector to See Healthy M&A Activity in 2024: PwC

After a “reasonably strong year” in 2023, next year will see “similar levels” of M&A activity with increased investor interest in weight loss and cardiovascular diseases, contends professional services firm PwC.

December 14, 2023
·
3 min read
·
Tristan Manalac
Policy

White House Hits Pharma Again, Requires Rebates Over Drug ‘Price Gouging’

The Biden administration on Thursday said 48 drugs covered under Medicare’s Part B may be subject to inflation rebates in the first quarter of 2024 under the Inflation Reduction Act.

December 14, 2023
·
2 min read
·
Kate Goodwin
Drug Development

Moderna, Merck Cancer Vaccine-Keytruda Combo Gets Win at Three-Year Mark

The combination of Keytruda and an mRNA vaccine reduced the risk of death or relapse in patients with the most deadly form of skin cancer after three years in a Phase IIb study.

December 14, 2023
·
2 min read
·
Tyler Patchen
Policy

Supreme Court Takes Up Abortion Pill Case, Decision Expected Amid 2024 Election

The U.S. Supreme Court has agreed to the Biden administration’s request to review lower-court rulings that would curtail access to the abortion pill mifepristone, with a decision expected in the summer.

December 14, 2023
·
2 min read
·
Tristan Manalac
Deals

What VCs really think of the market right now with MPM Capital, Endeavor and Two Bear Capital

What needs to happen for funding in biopharma to bounce back? BioSpace’s Lori Ellis discusses the macroeconomic environment and biopharma funding outlook with venture capital guests Ansbert Gadicke, Martin Gershon and Mike Goguen.

December 14, 2023
·
1 min read
·
BioSpace Insights
Pharm Country

TMRW Life Sciences Expands Globally Entering UK Fertility Market

TMRW Life Sciences, a fertility technology company automating the IVF lab, announced its global expansion with the adoption of its technology in the United Kingdom.

December 14, 2023
·
4 min read
Business

Brenus Pharma Joins the Paris Saclay Cancer Cluster (PSCC) to Collaborate at the Heart of Innovation in Oncology

Brenus Pharma has successfully joined the Paris Saclay Cancer Cluster, the first national Onco-cluster.

December 14, 2023
·
1 min read
Nerviano Medical Sciences and Italfarmaco Announce Licensing of Linker-Payload Technology to Develop and Commercialize a Novel Peptide-Drug Conjugate

Nerviano Medical Sciences S.r.l., a clinical-stage biotechnology company member of NMS group, announced the signing of a license agreement with Italfarmaco S.p.A., a specialty pharmaceutical company, to develop and commercialize a novel peptide-drug conjugate.

December 14, 2023
·
5 min read
Pharm Country

GenScript to Host Biotech Global Forum 2024 during 42nd Annual J.P. Morgan Healthcare Conference

GenScript Biotech Corporation, the world’s leading provider of life-science research tools and services, is kicking off 2024 with the GenScript Biotech Global Forum 2024, concurrent with the 42nd Annual J.P. Morgan Healthcare Conference.

December 14, 2023
·
2 min read
Drug Development

Clearside Biomedical Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD

Clearside Biomedical, Inc. (Nasdaq: CLSD) announced today that it has completed randomization in its ODYSSEY Phase 2b clinical trial of CLS-AX (axitinib injectable suspension) in neovascular age-related macular degeneration (wet AMD).

December 14, 2023
·
7 min read